Abstract:Background Microbiota-host interactions are crucial in the progression of inflammatory bowel disease (IBD). Despite extensive research, the detailed mechanisms through which these interactions influence the disease's development and progression remain largely unclear. Understanding these intricate processes is essential for developing targeted therapies and improving patient outcomes. Methods Male C57BL/6 mice were used for all experiments. Enterotoxigenic Bacteroides fragilis (ETBF) was administered orally to induce colitis, while control groups received non-toxigenic Bacteroides fragilis. Both bacterial strains were cultured under anaerobic conditions before gavage. Post-treatment, intestinal tissues were collected, and macrophages were isolated using collagenase digestion followed by magnetic cell sorting (MACS). Total RNA from these macrophages was extracted, and m6A modifications were analyzed via m6A-specific antibodies and high-throughput sequencing. Quantitative reverse transcription PCR (qRT-PCR) and Western blot were employed to measure expression levels of METTL3, FOXD3, ITGA5, and inflammatory markers. The role of FOXD3 in regulating METTL3 transcription was assessed using specific inhibitors or siRNA. Results Here, we reveal that Enterotoxigenic Bacteroides fragilis (ETBF) induces a dramatic reduction of m6A modifications in intestinal inflammatory macrophages, contributing to the initiation of IBD progression. Mechanistically, we characterize B fragilis toxin (BFT), produced by ETBF, which reduces METTL3 transcription by inhibiting FOXD3 expression and promotes the expression of its target integrin subunit alpha 5 (ITGA5) expression by diminishing YTHDF2-dependent mRNA degradation. Targeting ITAG5 using Cilengitide significantly alleviated ETBF-induced colitis by decreasing the level of inflammatory factors in macrophages. Conclusions Our research offers valuable insights into how the gut microbiota modulates the m6A epitranscriptome in human macrophages. This modulation plays a significant role in the progression of inflammatory bowel disease (IBD). By elucidating these complex interactions, our findings contribute to a deeper understanding of IBD pathogenesis and highlight potential avenues for therapeutic intervention.

Bacteroides Fragilis Controls Intestinal Inflammation Through Promoting Treg Differentiation Via TGF-β/Smad3 Signaling Pathway

Bacteroides Fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses

Bacteroides fragilis strain ZY-312 facilitates colonic mucosa regeneration in colitis via motivating STAT3 signaling pathway induced by IL-22 from ILC3 secretion

Protective Effect of Bacteroides fragilis on TNF-α- Induced Inflammatory Changes in Human Colon Epithelial Cells and in Inflammatory Bowel Disease Mouse Model

Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism

Protective effects of a new generation of probiotic Bacteroides fragilis against colitis in vivo and in vitro

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Novel strains of Bacteroides fragilis and Bacteroides ovatus alleviate the LPS-induced inflammation in mice

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis

Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation

BACTERIAL SPHINGOLIPIDS EXACERBATE COLITIS BY INHIBITING ILC3-DERIVED IL-22 PRODUCTION

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating AHR/NRF2/NLRP3 Inflammasome Pathways through Indole-3-lactic Acid Production

IDDF2024-ABS-0381 Bacteroides Fragilis Toxin Suppresses METTL3-mediated M6a Modification in Macrophage to Promote Inflammatory Bowel Disease

Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice

Monocolonization of Germ-Free Mice with Bacteroides fragilis Protects against Dextran Sulfate Sodium-Induced Acute Colitis

Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis

<i>Bifidobacterium bifidum</i> H3-R2 and Its Molecular Communication within the Context of Ulcerative Colitis

The roles of different Bacteroides fragilis strains in protecting against DSS-induced ulcerative colitis and related functional genes

Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis